Webinar: Investing for Launch Success
In this webinar, you will:
- Identify the challenges and potential pitfalls to plan for when developing your launch strategy
- Understand the critical investment decisions that significantly impact launch success
- Investigate new ways of approaching launch to manage challenges and achieve results
Launching a new drug is complex. And too often, launches fail to meet expectations.
A successful launch must overcome a series of barriers, including intensifying competition, increasing pricing pressure, growing access challenges and rising expectations among caregivers and patients. These pressures are here to stay and will impact the future launch environment.
Companies need to consider new ways of approaching launch to manage challenges and achieve expected results. Challenges need to be met head-on and addressed by planning early, defining your market and knowing the value of your product. A strategic approach that identifies when in the commercial development cycle to invest resources, how much to invest and which commercial functions to prioritize is critical to launch success.
This session will discuss ways companies can overcome challenges and plan for success in a complex launch environment.
Meet Our Speakers:
Senior Managing Director, Head of Product and Franchise Strategy, Consulting
Naveen Murthy brings over twenty years in biotechnology/pharmaceutical consulting, as well as experience in the biotechnology industry and a strong marketing, financial and strategy background to his work at Syneos Health.
Before joining Syneos Health, Mr. Murthy was a Summer Associate at Pfizer, Inc. He has also worked at GlycoGenesys, Inc. in a business development and project management function. Mr. Murthy has authored several scientific articles and abstracts that have been published in industry journals.
Mr. Murthy earned his MBA from New York University’s Leonard N. Stern School of Business, with specializations in finance, accounting and business law. He also earned a BS with a major in biology and a minor in economics from Tufts University.
Managing Director, Commercial Advisory Group, Consulting
Michael Sarshad brings 17 years of healthcare experience to serve customers of the Syneos Health Commercial Advisory Group. Mr. Sarshad has experience in product launch strategy and planning, brand planning, cross-divisional synergies, business development, operational excellence, market access and medical affairs.
Prior to joining Syneos Health, Mr. Sarshad spent time at Bayer HealthCare Pharmaceuticals working on projects that involved identifying potential synergies, evaluating merger and acquisition opportunities, helping implement process improvements, performing market research and generating proposals for senior management regarding greenfield opportunities. Prior to this role, Mr. Sarshad was the director of marketing at a multi-million-dollar dermatology practice in Los Angeles.
Mr. Sarshad earned his MBA in pharmaceutical management and marketing with honors from Rutgers University. During his time at Rutgers, he was the president of the Pharmaceutical Management Club and won multiple prestigious pharmaceutical and biotechnology case competitions. He earned his BS in management science and chemistry from the University of California, San Diego.